PASG
Passage Bio, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website assagebio.com
- Employees(FY) 85
- ISIN US7027121000
Performance
-14.6%
1W
-29.72%
1M
-39.37%
3M
-15.73%
6M
-21.37%
YTD
-2.67%
1Y
Profile
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. Passage Bio, Inc. has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Technical Analysis of PASG 2024-05-31
Overview:
In analyzing the technical indicators for PASG over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been consistently below the closing price, ind...
Recent News & Updates
- 2022-07-27 19:30
- 2022-07-21 04:01
- 2022-07-11 20:19
- 2022-07-05 19:00
- 2022-06-08 19:30
- 2022-06-07 19:30
- 2022-05-31 22:19
Passage Bio and CEO Bruce Goldsmith part ways(Bizjournals)
- 2022-05-31 19:30
Passage Bio Announces Leadership Transition(Yahoo Finance)
- 2022-05-20 04:01
- 2022-05-17 19:00
- 2022-05-15 19:00
- 2022-05-08 19:00
- 2022-05-03 22:55
- 2022-05-03 02:13
- 2022-05-02 04:01
- 2022-04-22 04:01
- 2022-03-28 19:00
- 2022-03-27 19:00
Passage Bio to Participate in Upcoming Investor Conferences(Yahoo Finance)
- 2022-03-14 23:22
- 2022-03-14 23:12
- 2022-03-14 19:00
- 2022-03-09 18:00
- 2022-03-02 18:00
- 2022-02-28 18:00
- 2022-02-23 18:00
- 2022-02-10 22:00
- 2022-01-31 23:49
- 2022-01-30 18:00
- 2022-01-09 18:00
- 2022-01-02 18:00